null

Oral Cancer risk factors

The main causes of oral cancer have long been known and many cases of the disease could be prevented. The most important aetiological factors are tobacco usage and excess consumption of alcohol, the two acting separately and synergistically. In developed countries, the risk of oral cancer attributable to these two factors combined is estimated to be more than 80%.1 A deficient diet also predisposes towards the development of oral cancers and it has been estimated that this may be responsible for 10-15% of cases in Europe.2 For lip cancers only, over exposure to UV light is implicated.

This page presents oral cancer risk factors including tobacco, alcohol, diet and nutrition, ultraviolet light and other factors.

Tobacco and oral cancer risk

Tobacco consumption can take many forms and over 90% of patients with oral cancer use tobacco in some form.

In the UK, cigarette, cigar and pipe smoking are the main forms of tobacco use and all are causes of oral cancer.3 In the earlier parts of the last century, pipe smoking was associated with lip cancer (most lip cancers arise on the lower lip) and its decline in popularity may be linked with some of the decrease in lip cancer. A recent case control study in Spain showed an increased risk of lip cancer when smokers were in the habit of leaving the cigarette on the lip.4 Since the 1920s smoking cigarettes has been the main form of tobacco use in the UK. The risk of oral cancer associated with smoking is both dose and duration dependent while smoking cessation leads to a fall in risk.1,5,6 The excess risk of oral cancer from smoking almost disappears within 10 years of giving up.7

In 2003, it was estimated that of the 28% of British men who smoked, 4% smoked cigars and 1% pipes.8 Very few women in the UK smoke pipes or cigars. In one case control study of oral cancer carried out in Cuba, the odds ratio associated with smoking 30 or more cigarettes a day was comparable with that for smoking 4 or more cigars a day. Indian women who practice reverse chutta smoking, with the lighted end of the cigar inside the mouth, have particularly high rates of oral cancer of the palatal mucosa.9 Smoking bidi(s) which are made of hand-rolled tobacco wrapped in tendu leaf also increases the risk of oral cancer.10

A recent evaluation by the International Agency for Research on Cancer (IARC) has confirmed that smokeless tobacco is also carcinogenic.11,12 In the UK and Europe (with the notable exception of Sweden) the use of smokeless tobacco is rare except in minority ethnic groups (see next paragraph).13 In the USA it is a major problem with a reported 6% of the adult male population as regular users14. In some areas, particularly the southern states, the prevalence is much higher with up to a third of young men using smokeless tobacco.15

The primary cause of the very high incidence of oral cancer in South Asia is the widespread habit of chewing betel quid (or paan) and related areca nut use.16 Chewing betel is thought to date back at least 2000 years and worldwide an estimated 200-400 million people practice the habit.17 The components of the betel quid vary between different populations but the main ingredients are the leaf of the vine, Piper betel, areca nuta, slaked lime (calcium hydroxide) and spices.18 Tobacco was introduced to South Asia in the seventeenth century. Areca nut is carcinogenic to humans and the risk of oral cancer is increased with chewing pan without tobacco, although the risk is higher for paan containing tobacco.19-21 As with smoking tobacco, risk is dependent on dose and duration of use.22 Among Asian communities in the UK, Bangladeshis are particularly likely to retain the habit of betel quid chewing as Figure 4.1 shows with one-fifth of men and one-quarter of women using smokeless tobacco.23,24 The prevalence of tobacco chewing increases with age, especially among women. The most commonly used chewing tobacco product is paan with tobacco (used by 14% of Bangladeshi men and 23% of Bangladeshi women).

Figure 4.1: Percentage of South Asians in the UK that use any form of chewing tobacco, 1999

Download this chart (15KB)

Oral cancer patients are at risk of developing second primary tumours in the upper aerodigestive tract but their risk of doing so is reduced if they cease to use tobacco after the initial primary is diagnosed.25,26

Although oral cancers are strongly associated with smoking, the oral cancer mortality trends in England and Wales do not match the decreasing trends in smoking (see section on Lung cancer and smoking) in the same way that lung cancer trends do. This suggests that smoking acts in a complex way, possibly with other risk factors, to promote the disease.27

Alcohol and oral cancer risk

Alcohol is the second major risk factor for oral cancer with 75-80% of patients frequently consuming alcohol. For non-smokers it is the most important risk factor. Above 30 grams of alcohol per day, risk increases linearly with amount of alcohol consumed.1 People who both drink and smoke have a much higher risk of oral cancer than those using only alcohol or tobacco as Figure 4.2 demonstrates using US data.28

Figure 4.2: Relative risk of oral/pharyngeal cancer in males by alcohol/tobacco consumption using US measures

Download this chart (27KB)

Heavy drinkers and smokers have 38 times the risk of abstainers from both products. It has been suggested that it is the total amount of ethanol ingested rather than the type of product (beer, wine, spirits) which is important.29 However, in a recent case control study in Spain, although risk did increase linearly with increasing ethanol content, there was an independent effect of type of alcohol with spirit drinkers 2 or 3 times more at risk of developing oral cancer than drinkers of only wine or beer.5 The rising trends in oral cancer mortality in Europe have been related to increasing levels of alcohol consumption. For example, in Denmark the alarming increase in oral cancers has been attributed predominantly to greater alcohol consumption.30 An exception to this rise in alcohol consumption is seen in France, where a decrease in alcohol consumption has been linked to the fall in oral cancer mortality rates in the 1980s.31

In the UK, consumption of alcohol has more than doubled since the middle of the last century, from 3.9 to 8.6 litres of pure alcohol per head per year– see Figure 4.3.32,33

Figure 4.3: Alcohol consumption in the UK, 1900-2000, per capita consumption of 100 per cent alcohol

Download this chart (30.5KB)

The percentage of the population who exceed the recommended weekly guideline of 21 units for men and 14 for women is steadily rising. b In 1988 around 10% of women and 26% of men exceeded the limits compared with 18% and 30% in 2002.34 The heaviest drinkers are aged 16-24 years and this age group is also the most likely to binge drink.33

At present the UK level of drinking (8.6 litres per year) is lower than in most European countries, for example, France (10.7 litres), Portugal (11.0 litres), Spain (9.9 litres) and Germany (10.6 litres). However, whereas consumption is either falling or stabilising in most of these countries, in the UK it is rising quickly. It is estimated that if current trends continue, the UK could rise to near the top of the consumption table within the next ten years.33 Co-ordinated and funded action is needed to tackle the UK’s complex drinking problems.35

Concern has also been expressed about the use of mouthwashes, particularly those with high alcoholic content.36 Further studies need to be carried out to clarify the role of mouthwashes and the development of oral cancer, but the avoidance of high alcoholic mouthwashes seems prudent.

Diet, nutrition and oral cancer risk

Dietary deficiencies, particularly of vitamin A (and related carotenoids), vitamin C, vitamin E, iron, selenium, folate and other trace elements have been linked to increased risk of oral cancer.37-39 Many studies have found that oral cancer patients have a history of low fruit and vegetable intake.40 Intervention studies where diets have been supplemented have shown some beneficial effect on pre-malignant conditions and reducing the risk of a second oral cancer but further work into diet and the role of chemoprevention in oral cancers is needed.2,41,42

Risk of oral cancer appears to fall with increasing body mass index (BMI). A recent case-control study in Spain reported a significant reduction in risk of oral cancer with higher BMI at diagnosis and two years prior to diagnosis, after adjustments for smoking, drinking, fruit and vegetable intake.43

Ultraviolet light and oral cancer risk

Solar irradiation is a major risk factor for cancer of the lip. The vast majority of lip cancers occur on the lower lip and many patients have outdoor occupations where sun exposure is increased. Lip cancer is three times more common in men than women which may be an effect of occupation, smoking and sun-exposure.4 The use of sunscreens and protective clothing would significantly reduce exposure.

Other oral cancer risk factors

The role of viruses remains unclear. Evidence is perhaps strongest for infection with high-risk human papillomaviruses (HPV).44-46 Studies show an increased risk of oral cancer in women with cervical cancer suggesting a common risk factor other than smoking, such as HPV infection: transmission of HPV via oral sex is one possibility. A recent multicentre case control study reported that infection with HPV16 increased the risk of cancer of the oral cavity and particularly oropharynx.47 The role of infection with Epstein-Barr virus and herpes simplex viruses remains uncertain.48,49 Renal transplant patients have been reported to be at increased risk of developing lip cancers50 which may be a result of immunosuppression. Poor oral hygiene and ill-fitting dentures may also play a role in localising a site where tumours may develop, but both this and oral sepsis are very unlikely to cause oral cancer in the absence of other well-established risk factors.

Several oral lesions and conditions precede oral carcinoma and the most common of these are leukoplakia and erythroplakiab. Leukoplakia has many clinical variants but is much less likely to progress to malignancy than erythroplakia. The precise prevalence of these conditions in the UK is unknown. Estimates of leukoplakia prevalence outside the UK range from 0.2 to 11.7% of the population and the prevalence of erythroplakia is considerably less.51 It has recently been estimated that the annual transformation rate of oral leukoplakia to oral squamous cell carcinoma may not exceed 1%.52 Erythroplakia is rare and mainly occurs in people aged over 60.53

Oral cancer risk in young and middle-aged adults

The rising incidence and mortality rates in young and middle-aged adults is incontrovertible, but there has been debate over the causes of this increase and whether their disease is inherently more aggressive than that occurring in older patients.48,54-56 A series of studies in southern England looking at risk factors for patients under 45 years concluded that most young patients are exposed to the traditional risk factors of tobacco smoking and alcohol while consumption of fresh fruit and vegetables is protective. 48,57,58 However, the relatively short duration of exposure to these known risk factors suggests that other factors may also be involved and there was a small sub-group of patients who had little, if any, exposure to the major risk factors.

In 1992 the Government recommended weekly limits. In 1995 this was amended to daily recommendations of 3-4 units for men and 2-3 units for women, with two non-drinking days after an episode of heavy drinking. One unit is 8g of alcohol, equivalent to half a pint of beer, one small (125ml) glass of wine and one measure of spirits. New recommendations are expected this year. The European Code against Cancer recommends lower limits of 2 drinks a day for men and 1 for women.

aareca nut is the seed of the fruit of the oriental palm, Areca catechu

bOther rare precancerous conditions include lichen planus, oral submucous fibrosis, syphilitic glossitis and sideropenic dysphagia.

References

  1. Rodriguez, T., et al., Risk factors for oral and pharyngeal cancer in young adults. Oral Oncol, 2004. 40(2): p. 207-13.
  2. La Vecchia, C., et al.,Epidemiology and prevention of oral cancer. Oral Oncol, 1997. 33(5): p. 302-12.
  3. Warnakulasuriya, S., G. Sutherland, and C. Scully,. Tobacco, oral cancer, and treatment of dependence. Oral Oncol, 2005. 41(3): p. 244-260
  4. Perea-Milla Lopez, E., et al., Lifestyles, environmental and phenotypic factors associated with lip cancer: a case-control study in southern Spain. Br J Cancer, 2003. 88(11): p. 1702-7.
  5. Castellsague, X., et al., .The role of type of tobacco and type of alcoholic beverage in oral carcinogenesis. Int J Cancer, 2004. 108(5): p. 741-749
  6. Blot, W.J., et al., Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res, 1988. 48(11): p. 3282-7.
  7. International Agency for Research on Cancer, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Tobacco smoke and involuntary smoking.Volume83 ed. Vol. 83. 2004, Lyon: IARC Press.
  8. Office for National Statistics. General Household Survey 2003/4. 2008
  9. Gupta, P.C., F.S. Mehta, and J.J. Pindborg, Mortality among reverse chutta smokers in south India. Br Med J (Clin Res Ed), 1984. 289(6449): p. 865-6.
  10. Rahman, M., J. Sakamoto, and T. Fukui, Bidi smoking and oral cancer: a meta-analysis. Int J Cancer, 2003. 106(4): p. 600-4.
  11. IARC, Monograph on the evaluation of carcinogenic risk to humans. Vol 89: smokeless tobacco and some tobacco-specific nitrosamines. 2004, Lyon: IARC Press.
  12. Cogliano, V., et al., Smokeless tobacco and tobacco-related nitrosamines. Lancet Oncol, 2004. 5(12): p. 708.
  13. Levy, D.T., et al., The relative risks of a low-nitrosamine smokeless tobacco product compared with smoking cigarettes: estimates of a panel of experts. Cancer Epidemiol Biomarkers Prev, 2004. 13(12): p. 2035-42.
  14. US Department of Health and Human Services, Smoking and Tobacco Control Monograph No.2.
  15. Rouse, B., Epidemiology of smokeless tobacco use: A national study. National Cancer Institute Monographs 8:29-33. 1989.Link
  16. Bedi, R., Betel quid and tobacco chewing among the United Kingdom's Bangladeshi community in The Proceedings of the CRC/DoH Symposium on Cancer and Minority Ethnic Groups. BJC, 1996. 74 Supplement.
  17. Gupta, P.C. and S. Warnakulasuriya, Global epidemiology of areca nut usage. Addict Biol, 2002. 7(1): p. 77-83.
  18. Warnakulasuriya, S., C. Trivedy, and T.J. Peters, Areca nut use: an independent risk factor for oral cancer. Bmj, 2002. 324(7341): p. 799-800.
  19. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Betel-quid and areca-nut chewing and some areca-nut related nitrosamines. 2004, IARC.
  20. Warnakulasuriya, K.A., Analytical studies of the evaluation of the role of betel quid in oral carcinogenesis. In Bedi R (ed) Betel quid and tobacco chewing among the Bangladeshi community in the United Kingdom. 1995, London: Centre for Transcultural oral health.Link
  21. van Wyk, C.W., et al., The areca nut chewing habit and oral squamous cell carcinoma in South African Indians. A retrospective study. S Afr Med J, 1993. 83(6): p. 425-9.
  22. Balaram, P., et al., Oral cancer in southern India: the influence of smoking, drinking, paan-chewing and oral hygiene. Int J Cancer, 2002. 98(3): p. 440-5.
  23. Ahmed, S., A. Rahman, and S. Hull, Use of betel quid and cigarettes among Bangladeshi patients in an inner-city practice: prevalence and knowledge of health effects. Br J Gen Pract, 1997. 47(420): p. 431-4.
  24. Department of Health, Health Survey for England. The Health of Minority Ethnic Groups 1999. 2001.
  25. Scully, C. and S. Porter, ABC of oral health. Oral cancer. Bmj, 2000. 321(7253): p. 97-100.
  26. Warnakulasuriya, K.A., D. Robinson, and H. Evans, Multiple primary tumours following head and neck cancer in southern England during 1961-98. J Oral Pathol Med, 2003. 32(8): p. 443-9.
  27. Doll, R., S. Darby, and E. Whitley, Trends in mortality from smoking related diseases in Charlton J and Murphy M (eds). The Health of Adult Britain. Vol. 1. 1997: TSO.Link
  28. Blot, W., Alcohol and cancer. Cancer Research, 1992. (suppl) 52: p. 2119-2123.
  29. Boyle, P., et al., European Code Against Cancer and scientific justification: third version (2003). Ann Oncol, 2003. 14(7): p. 973-1005.
  30. Moller, H., Changing incidence of cancer of the tongue, oral cavity, and pharynx in Denmark. J Oral Pathol Med, 1989. 18(4): p. 224-9.
  31. Blot, W., Oral and Pharyngeal cancers in Doll R (ed). Trends in Cancer Incidence and Mortality. Vol. 19/20, 23-42.1994: Cancer Surveys.
  32. British Beer and Pub Association, Statistical Handbook: A compilation of drinks industry statistics. 2002, London.
  33. Prime Minister's Strategy Unit, Alcohol Harm Reduction Project: Interim Analytical Report. 2004: London.
  34. ONS, Living in Britain: Results from the 2002 General Household Survey. 2004, TSO: London.
  35. Editorial, Time for coordinated action on alcohol. Lancet, 2004. 363(9414): p. 1001.
  36. P Boyle, GJ Macfarlane, and T.Z.e. al, Recent advances in epidemiology of head and neck cancer. Curr Opin Oncol, 1992(4): p. 471-477.
  37. Key, T.J., et al., Diet, nutrition and the prevention of cancer. Public Health Nutr, 2004. 7(1A): p. 187-200.
  38. Bosetti, C., et al., Influence of the Mediterranean diet on the risk of cancers of the upper aerodigestive tract. Cancer Epidemiol Biomarkers Prev, 2003. 12(10): p. 1091-4.
  39. Pelucchi, C., et al., Folate intake and risk of oral and pharyngeal cancer. Ann Oncol, 2003. 14(11): p. 1677-1681.
  40. Macfarlane, G.J., et al., Alcohol, tobacco, diet and the risk of oral cancer: a pooled analysis of three case-control studies. Eur J Cancer B Oral Oncol, 1995. 31B(3): p. 181-7.
  41. Sankaranarayanan, R., B. Mathew, and P.N.e. al, Chemoprevention of cancers of the oral cavity and head and neck. In Hakama M, Beral V, Buiatti E et al (eds). Chemoprevention in cancer control. 1996: IARC.Link
  42. Hunter, K.D., E.K. Parkinson, and P.R. Harrison, Opinion: Profiling early head and neck cancer. Nat Rev Cancer, 2005. 5(2): p. 127-35.
  43. Nieto, A., et al., Lifetime body mass index and risk of oral cavity and oropharyngeal cancer by smoking and drinking habits. Br J Cancer, 2003. 89(9): p. 1667-71.
  44. Gillison, M.L., Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol, 2004. 31(6): p. 744-54.
  45. Kreimer, A.R., et al., Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev, 2005. 14(2): p. 467-75.
  46. Smith, E.M., et al., Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. J Natl Cancer Inst, 2004. 96(6): p. 449-55.
  47. Herrero, R., et al., Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst, 2003. 95(23): p. 1772-83.
  48. Llewellyn, C.D., N.W. Johnson, and K.A. Warnakulasuriya, Risk factors for oral cancer in newly diagnosed patients aged 45 years and younger: a case-control study in Southern England. J Oral Pathol Med, 2004. 33(9): p. 525-32.
  49. Mucci L, A.H.-O., Textbook of cancer epidemiology: Chapter Six: Oral and Pharyngeal Cancer. 2002.Link
  50. King, G.N., et al., Increased prevalence of dysplastic and malignant lip lesions in renal-transplant recipients. N Engl J Med, 1995. 332(16): p. 1052-7.
  51. Rodrigues, V.C., S.M. Moss, and H. Tuomainen, Oral cancer in the UK: to screen or not to screen. Oral Oncol, 1998. 34(6): p. 454-65.
  52. Scheifele, C. and P.A. Reichart, Is there a natural limit of the transformation rate of oral leukoplakia? Oral Oncol, 2003. 39(5): p. 470-5.
  53. Scully, C. and S. Porter, ABC of oral health. Swellings and red, white, and pigmented lesions. Bmj, 2000. 321(7255): p. 225-8.
  54. Oliver, R.J., J. Dearing, and I. Hindle, Oral cancer in young adults: report of three cases and review of the literature. Br Dent J, 2000. 188(7): p. 362-5.
  55. Hyam, D.M., et al., Tongue cancer: do patients younger than 40 do worse? Aust Dent J, 2003. 48(1): p. 50-4.
  56. Annertz, K., et al., Incidence and survival of squamous cell carcinoma of the tongue in Scandinavia, with special reference to young adults. Int J Cancer, 2002. 101(1): p. 95-9.
  57. Llewellyn, C.D., et al., Squamous cell carcinoma of the oral cavity in patients aged 45 years and under: a descriptive analysis of 116 cases diagnosed in the South East of England from 1990 to 1997. Oral Oncol, 2003. 39(2): p. 106-14.
  58. Llewellyn, C.D., et al., An analysis of risk factors for oral cancer in young people: a case-control study. Oral Oncol, 2004. 40(3): p. 304-13.

Previous section - Survival
Next section - Symptoms and treatment

Select the cancer you are interested in

A - Z index A - Z index
Contact us Contact us
Donate now Donate now
Glossary Glossary
Print this page Print this page

Our publications

Find out more
 
Page last updated: April 2005
 
 
About this site   Accessibility   Donate now   Privacy   Site Map   Terms & Conditions   Top of page

Cancer Research UK is a registered charity No. 1089464.
Registered as a company limited by guarantee in England & Wales No. 4325234.
Registered address 61 Lincoln's Inn Fields, London, WC2A 3PX.